20-02-2026
Gaudium IVF IPO LIVE updates as GMP signals an 11% listing pop and issue booked 8% so far
The IPO price band is fixed at ₹75–₹79 per share, valuing the company at around ₹575 crore. The issue has attracted investor attention in the primary market. As per market observers, the grey market premium signals a potential 11% listing gain. Investors are closely tracking subscription trends and GMP ahead of listing.
Gaudium IVF and Women Health IPO opened for subscription on February 20 and will close on February 24, aiming to raise ₹165 crore. Ahead of the launch, the company secured ₹49.5 crore from anchor investors by allotting 62,65,860 shares at ₹79 per share. The price band for the IPO has been fixed at ₹75–79 per share, valuing the company at around ₹575 crore. The issue comprises a fresh issue of 1.14 crore equity shares and an offer for sale of nearly 95 lakh shares by promoter Manika Khanna. Proceeds from the fresh issue will be used to establish 19 new IVF centres, repay debt, and meet general corporate requirements. For FY25, the company reported revenue of ₹70.72 crore and a profit after tax of ₹19.13 crore, compared to ₹47.89 crore revenue and ₹10.31 crore PAT in FY24. The current grey market premium stands at ₹8.5, indicating an estimated listing gain of around 11% over the upper price band, although the GMP has moderated from earlier levels. The shares are scheduled to list on February 27.